PlainRecalls
FDA Drug Critical Class I Terminated

NovoLog (Insulin aspart) Injection, 100 units/mL (U-100), One 10 mL multi-dose vial, Sample. Not for Resale, Rx Only, Manufactured by: Novo Nordisk A/S, Bagsvaerd, Denmark NDC 0169-7501-90

Reported: April 21, 2021 Initiated: March 22, 2021 #D-0616-2021

Product Description

NovoLog (Insulin aspart) Injection, 100 units/mL (U-100), One 10 mL multi-dose vial, Sample. Not for Resale, Rx Only, Manufactured by: Novo Nordisk A/S, Bagsvaerd, Denmark NDC 0169-7501-90

Reason for Recall

Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.

Details

Recalling Firm
Novo Nordisk Inc
Units Affected
N/A
Distribution
Nationwide in the USA
Location
Plainsboro, NJ

Frequently Asked Questions

What product was recalled?
NovoLog (Insulin aspart) Injection, 100 units/mL (U-100), One 10 mL multi-dose vial, Sample. Not for Resale, Rx Only, Manufactured by: Novo Nordisk A/S, Bagsvaerd, Denmark NDC 0169-7501-90. Recalled by Novo Nordisk Inc. Units affected: N/A.
Why was this product recalled?
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.
Which agency issued this recall?
This recall was issued by the FDA Drug on April 21, 2021. Severity: Critical. Recall number: D-0616-2021.